Insider · CIK 0001281197
Raymond D Matsumoto
Files at AX (Axos Financial, Inc.). First filing -, latest -.
In brief
Raymond D Matsumoto files SEC Form 4 as COO at AX (Axos Financial, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Raymond D Matsumoto has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 34 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | AX Axos Financial, Inc. | MOption exercise Common Stock | +4,946 | $92.68 | $458k | 46,579 | 27 d ago |
| Sep 15, 2026 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -2,668 | $92.68 | $247k | 43,911 | 27 d ago |
| Sep 15, 2026 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,946 | $0.00 | $0 | 12,167 | 27 d ago |
| Sep 15, 2026 | AX Axos Financial, Inc. | AGrant or award Restricted Stock Unitsderivative | +2,698 | $0.00 | $0 | 14,865 | 27 d ago |
| Mar 20, 2026 | AX Axos Financial, Inc. | MOption exercise Common Stock | +1,621 | $82.93 | $134k | 42,507 | Mar 24, 2026 |
| Mar 20, 2026 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -874 | $82.93 | $72k | 41,633 | Mar 24, 2026 |
| Mar 20, 2026 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,621 | $0.00 | $0 | 17,113 | Mar 24, 2026 |
| Mar 15, 2026 | AX Axos Financial, Inc. | MOption exercise Common Stock | +2,474 | $84.68 | $209k | 41,383 | Mar 16, 2026 |
| Mar 15, 2026 | AX Axos Financial, Inc. | MOption exercise Common Stock | +1,956 | $84.68 | $166k | 43,339 | Mar 16, 2026 |
| Mar 15, 2026 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -1,055 | $84.68 | $89k | 42,284 | Mar 16, 2026 |
| Mar 15, 2026 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -1,398 | $84.68 | $118k | 40,886 | Mar 16, 2026 |
| Mar 15, 2026 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,474 | $0.00 | $0 | 17,501 | Mar 16, 2026 |
| Mar 15, 2026 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,956 | $0.00 | $0 | 15,545 | Mar 16, 2026 |
| Mar 15, 2026 | AX Axos Financial, Inc. | AGrant or award Restricted Stock Unitsderivative | +3,189 | $0.00 | $0 | 18,734 | Mar 16, 2026 |
| Sep 23, 2025 | AX Axos Financial, Inc. | MOption exercise Common Stock | +2,491 | $88.46 | $220k | 39,800 | Sep 25, 2025 |
| Sep 23, 2025 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -891 | $88.46 | $79k | 38,909 | Sep 25, 2025 |
| Sep 23, 2025 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,491 | $88.46 | $220k | 19,975 | Sep 25, 2025 |
| Sep 15, 2025 | AX Axos Financial, Inc. | MOption exercise Common Stock | +2,241 | $90.29 | $202k | 37,060 | Sep 17, 2025 |
| Sep 15, 2025 | AX Axos Financial, Inc. | MOption exercise Common Stock | +1,635 | $90.29 | $148k | 38,695 | Sep 17, 2025 |
| Sep 15, 2025 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -585 | $90.29 | $53k | 38,110 | Sep 17, 2025 |
| Sep 15, 2025 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -801 | $90.29 | $72k | 37,309 | Sep 17, 2025 |
| Sep 15, 2025 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,241 | $0.00 | $0 | 20,889 | Sep 17, 2025 |
| Sep 15, 2025 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,635 | $0.00 | $0 | 19,254 | Sep 17, 2025 |
| Sep 15, 2025 | AX Axos Financial, Inc. | AGrant or award Restricted Stock Unitsderivative | +3,212 | $0.00 | $0 | 22,466 | Sep 17, 2025 |
| Mar 23, 2025 | AX Axos Financial, Inc. | MOption exercise Common Stock | +1,863 | $64.21 | $120k | 35,822 | Mar 25, 2025 |
| Mar 23, 2025 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -1,003 | $64.21 | $64k | 34,819 | Mar 25, 2025 |
| Mar 23, 2025 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,863 | $0.00 | $0 | 23,130 | Mar 25, 2025 |
| Mar 20, 2025 | AX Axos Financial, Inc. | AGrant or award Restricted Stock Unitsderivative | +4,865 | $0.00 | $0 | 24,993 | Mar 21, 2025 |
| Mar 15, 2025 | AX Axos Financial, Inc. | MOption exercise Common Stock | +1,955 | $63.94 | $125k | 33,946 | Mar 18, 2025 |
| Mar 15, 2025 | AX Axos Financial, Inc. | MOption exercise Common Stock | +2,473 | $63.94 | $158k | 36,419 | Mar 18, 2025 |
| Mar 15, 2025 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -1,052 | $63.94 | $67k | 35,367 | Mar 18, 2025 |
| Mar 15, 2025 | AX Axos Financial, Inc. | DDisposition to issuer Common Stock | -1,408 | $63.94 | $90k | 33,959 | Mar 18, 2025 |
| Mar 15, 2025 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,955 | $0.00 | $0 | 22,601 | Mar 18, 2025 |
| Mar 15, 2025 | AX Axos Financial, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,473 | $0.00 | $0 | 20,128 | Mar 18, 2025 |
Questions about Raymond D Matsumoto
Answered from the filings on this page, as of the latest one.
Is Raymond D Matsumoto buying or selling?
Raymond D Matsumoto has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Raymond D Matsumoto's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Raymond D Matsumoto has 0.
Where does Raymond D Matsumoto file Form 4?
Raymond D Matsumoto has filed Form 4 at AX (Axos Financial, Inc.) as EVP, Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.